InvestorsHub Logo
Followers 52
Posts 9089
Boards Moderated 1
Alias Born 10/25/2007

Re: None

Tuesday, 07/11/2023 12:01:38 AM

Tuesday, July 11, 2023 12:01:38 AM

Post# of 13461
Merck, Moderna unveil phase 3 trial details for closely watched mRNA cancer vaccine

The vaccine is made by profiling each patient’s tumor mutational signature and is designed to induce an immune response against the corresponding antigens. If eventually successful, Merck and Moderna could open up an entirely new area of cancer treatment.

https://www.fiercebiotech.com/biotech/merck-moderna-post-phase-3-trial-closely-watched-mrna-cancer-vaccine
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News